Oracle (ORCL) Stock Forecast & Price Target

$116.43 -3.47 (-2.89%)

As of 09:39 AM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 39 Analyst Ratings

Sell
1

Hold
8

Buy
30

Based on 39 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 39 analysts, 1 has given a sell rating, 8 have given a hold rating, 28 have given a buy rating, and 2 have given a strong buy rating for ORCL.

Consensus Price Target

$265.03
127.63% Upside

According to the 39 analysts' twelve-month price targets for Oracle, the average price target is $265.03. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $145.00. The average price target represents a forecasted upside of 127.63% from the current price of $116.43.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 7/28/25 to 7/28/26	1 Month Ago 6/28/25 to 6/28/26	3 Months Ago 4/29/25 to 4/29/26	1 Year Ago 7/28/24 to 7/28/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	28 Buy rating(s)	28 Buy rating(s)	28 Buy rating(s)	21 Buy rating(s)
Hold	8 Hold rating(s)	7 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$265.03	$268.27	$259.56	$218.29
Forecasted Upside	127.63% Upside	80.43% Upside	58.42% Upside	-11.87% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Computer and Technology Companies	Broader Market
Consensus Rating Score	2.79	2.29	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	120.86% Upside	206.18% Upside	13.32% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/23/2026	Guggenheim 5 of 5 stars	John DiFucci 2 of 5 stars	Reiterated Rating	Buy
7/20/2026	Weiss Ratings 5 of 5 stars		Downgrade	Hold (C+) ➝ Hold (C)
7/20/2026	CLSA 2 of 5 stars	Bhavtosh Vajpayee Not Rated	Initiated Coverage	Hold	$145.00	+14.64%
6/11/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
6/11/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$319.00 ➝ $325.00	+80.35%
6/11/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$225.00	+11.92%
6/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
6/11/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Mixed
Get the Latest News and Ratings for ORCL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oracle and its competitors with MarketBeat's FREE daily newsletter.
6/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$240.00 ➝ $250.00	+24.35%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$325.00	+61.66%
6/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Sector Perform	$190.00	+6.09%
6/11/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$284.00	+58.85%
6/11/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$164.00	-7.38%
6/11/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $225.00	+11.92%
6/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$200.00 ➝ $220.00	+9.43%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $300.00	+42.48%
6/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$235.00 ➝ $275.00	+28.86%
6/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$320.00	+30.72%
6/2/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $285.00	+16.41%
5/7/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Neutral ➝ Buy	$255.00	+31.31%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Hold
3/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$275.00 ➝ $220.00	+33.49%
3/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $210.00	+40.36%
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
3/9/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$375.00 ➝ $300.00	+102.48%
3/5/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$400.00 ➝ $320.00	+106.62%
2/9/2026	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$160.00	+2.82%
2/5/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Outperform	$342.00 ➝ $285.00	+94.21%
1/12/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/26/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Bersey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$382.00	+85.95%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/25/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$175.00	-41.03%
Here’s Why Trump Won’t End The Iran War (Ad) Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end. Uncover the real reason Trump may never end this war
9/15/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nay Soe Naing Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$202.00 ➝ $306.00	+1.24%
9/10/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$377.00	+14.80%
6/18/2025	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:27 AM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 27, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle recently reported strong quarterly earnings, with earnings per share significantly exceeding analysts' expectations, indicating robust financial health and operational efficiency.
The company has a solid revenue growth trajectory, with a year-over-year increase of over 20%, showcasing its ability to expand its market presence and customer base.
Oracle's recent win of a substantial U.S. Department of Defense software contract worth up to $7 billion could enhance its government business and drive future revenue growth.
The current stock price is around $159, which may present a favorable entry point for investors looking to capitalize on potential future growth.
With a dividend yield of approximately 1.7% and a payout ratio of 34.31%, Oracle offers a reliable income stream for investors while maintaining a healthy balance for reinvestment in growth initiatives.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Despite recent successes, there are concerns regarding Oracle's ability to quickly convert its AI infrastructure demand into profits, which could impact future earnings.
The company faces significant competition in the cloud and enterprise software markets, which may pressure margins and limit growth potential.
Insider selling activity, such as the recent sale of 400,000 shares by a Vice Chairman, may raise red flags about the company's future prospects and insider confidence.
Market sentiment remains mixed, with some analysts questioning whether Oracle can sustain its growth momentum amid evolving technology trends.
With a high return on equity of 58.62%, while indicative of strong profitability, it may also suggest that the company is operating at a high risk, which could deter more conservative investors.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 39 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $265.03, with a high forecast of $400.00 and a low forecast of $145.00.

39 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last year. There is currently 1 sell rating, 8 hold ratings, 28 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 127.63% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 1 upgrade and 1 downgrade by analysts.

Oracle has been rated by research analysts at Arete Research, Bank of America, Barclays, BMO Capital Markets, BTIG Research, Cantor Fitzgerald, Citigroup, CLSA, DA Davidson, Evercore, Guggenheim, KeyCorp, Mizuho, Moffett Nathanson, Morgan Stanley, Oppenheimer, Piper Sandler, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, TD Cowen, UBS Group, Wedbush, Weiss Ratings, and Wolfe Research in the past 90 days.

Analysts like Oracle more than other "computer and technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

This page (NYSE:ORCL) was last updated on 7/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle
Bull Case

Oracle
Bear Case

ORCL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle Bull Case

Oracle Bear Case

ORCL Forecast - Frequently Asked Questions

What is Oracle's forecast for 2026?

Should I buy or sell Oracle stock right now?

Does Oracle's stock price have much upside?

Has Oracle been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Oracle?

Do Wall Street analysts like Oracle more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Oracle
Bull Case

Oracle
Bear Case